Taysha Gene Therapies, Inc. (TSHA) Earnings
NASDAQ·Healthcare·Biotechnology
$5.73
+5.13%
Mkt Cap $1.77B
EPS — Estimate vs Actual
Mkt Cap
$1.77B
P/E
—
Fwd P/E
—
P/S
237.42
Rev TTM
—
EPS TTM
-$0.38
NASDAQ·Healthcare·Biotechnology
$5.73
+5.13%
Mkt Cap $1.77B
Mkt Cap
$1.77B
P/E
—
Fwd P/E
—
P/S
237.42
Rev TTM
—
EPS TTM
-$0.38